Cas:100501-58-4 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine manufacturer & supplier

We serve Chemical Name:1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine CAS:100501-58-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine

Chemical Name:1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine
CAS.NO:100501-58-4
Synonyms:1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine
Molecular Formula:C7H11N3
Molecular Weight:137.18200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.85000
Exact Mass:137.09500
LogP:0.39460

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine Use and application,1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine technical grade,usp/ep/jp grade.


Related News: Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine manufacturer ��The number of confirmed cases of coronavirus in Taiwan is not higher than in most countries affected,�� Mr. Wu said. ��Other than China, no other country, no other country has had its flight banned by Italy.�� 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine supplier At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival. 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine vendor Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 1-Methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine factory At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival.